Significant Changes to the 8th Edition of Standards for Cellular Therapy Services

Please note: AABB reserves the right to make updates to this program.

Live Program: Wednesday, June 21, 2017 - On-Demand Available

Master Program Number: 117EL-125 (see program format numbers below under Registration)

Educational Track: Quality Education
Topic: Cellular Therapies
Intended Audience: Physicians, Scientists, Nurses, Technologists, Perfusionists, Managers/Supervisors, CEOs/CFOs
Teaching Level: Basic

Director/Moderator: Christopher Bocquet, Director of Standards, AABB, Bethesda, MD
Speaker: Richard Haspel, MD, PhD, Transfusion Medicine Physician, Beth Israel Deaconess Medical Center, Boston, MA

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Explain the rationale for revised requirements.
  • Identify ways to implement the new and revised requirements.
  • Identify existing policies, processes, and procedures that may need to be changed in order to conform to the 8th Edition.
Program Description

This program will introduce the 8th Edition of Standards for Cellular Therapy Services. The speaker will summarize the new and revised requirements incorporated into the 8th Edition of Standards. These changes include the expansion of informed consent requirements, the addition of a standard to respond to emerging infectious diseases, and the implementation of ISBT 128 labeling of cellular therapy products. In addition, the rationale for the changes will be reviewed.


   Program #
Single Viewer: On-Demand Register17EL-4070-125
Group Viewing: On-Demand Register17EL-8070-125